Area Dose Response of Prevalent Childhood Thyroid Cancers after the Fukushima Nuclear Power Plant Accident
Area Dose Response of Prevalent Childhood Thyroid Cancers after the Fukushima Nuclear Power Plant Accident
Download Citation in txt
Download Citation in bib
Download Citation in ris
Author Info
Corresponding Author
Toshiko KatoIndependent Researcher, Nara, Japan
A B S T R A C T
Background and Methods: After the Fukushima Nuclear Power Plant accident, thyroid ultrasound screening was carried out on all residents of ages≤18 years at the accident. In order to find the cause for thyroid cancer prevalence, area dose dependence of childhood thyroid cancer proportion in the first and second round screening (E-I, E-II), and in 6 years as a whole (E-I+II) was analyzed for external dose estimated by Fukushima Health Management Survey and effective dose estimated by UNSCEAR. The results were analyzed by the regression analysis of Microsoft Excel. Results: Thyroid cancer incidence within 4-6 years and prevalence in 6 years after the accident had tendency to increase with doses. In OM-model according to Ohira’s map, thyroid cancer prevalence in E-I+II after 6 years showed linear prevalence-effective dose response with positive coefficient 5.6 (CI=3.4-7.9) (cancer cases / 100,000 / mSv) in the 1.6–5 mSv range. In F-model according to official regional division, thyroid cancer proportion in E-II and E-I+II showed linear response to UNSCEAR effective dose with R2>0.86 and p<0.075. This correlation was higher than the correlation between external dose and effective dose with R2=0.71. Conclusion: The observed linear area dose relation in 6 years after exposure suggests highly probable association between childhood thyroid cancer in Fukushima and radiation exposure. UNSCEAR effective dose was found to give the best fit to linear regression line for E-II and E-I+II, irrespective of models. Linear dose response for reasonable area division can be a direct evidence for radiation related thyroid cancer because linear dose response cannot be observed in mass-screening for sporadic thyroid cancers.
Article Info
Article Type
Research ArticlePublication history
Received: Mon 02, Dec 2019Accepted: Fri 20, Dec 2019
Published: Thu 26, Dec 2019
Copyright
© 2023 Toshiko Kato. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.DOI: 10.31487/j.COR.2019.06.16